"Triple O Research Institute is a clinical research center that delivers novel therapy and provides better healthcare and early access to new kinds of therapy. Through the quality of our work, our experienced professionals guarantee accurate results from our research."

During the past decade, Triple O Research Institute, P.A. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 16 clinical trials were completed, i.e. on average, 106.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Triple O Research Institute, P.A." #1 sponsor was "Gilead Sciences" with 15 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Aevi Genomic Medicine, LLC, a Cerecor company" with 1 trials sponsored, "Alexion" with 1 trials sponsored and "Basilea Pharmaceutica" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Triple O Research Institute, P.A." #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Triple O Research Institute, P.A." are "HIV Infections" (6 trials), "HIV-1 Infection" (6 trials), "HIV-1-infection" (5 trials), "HIV" (3 trials) and "Acquired Immunodeficiency Syndrome" (2 trials). Many other conditions were trialed in "Triple O Research Institute, P.A." in a lesser frequency.

Most popular intervention types in "Triple O Research Institute, P.A." are "Drug" (26 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "B/F/TAF" (7 trials), "Placebo" (4 trials), "E/C/F/TAF" (3 trials), "Oral Lenacapavir" (3 trials) and "Subcutaneous Lenacapavir" (3 trials). Other intervention names were less common.

The vast majority of trials in "Triple O Research Institute, P.A." are 23 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Triple O Research Institute, P.A.". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Triple O Research Institute, P.A., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Triple O Research Institute, P.A., 8 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".